Oita, Japan

Yoshie Yasumatsu

This inventor holds 4 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignees: Kohjin Life Sciences Co., Ltd., Mitsubishi Corporation Life Sciences Limited. Active years: 2019-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshie Yasumatsu. Retrieved from https://idiyas.com/inventor/yoshie-yasumatsu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 50.0

 

Average Co-Inventor Count = 3.2

ph-index = 1


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Yoshie Yasumatsu: Pioneering Female Inventor from Oita

Introduction: Yoshie Yasumatsu is a trailblazing inventor hailing from Oita, Japan, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Yoshie Yasumatsu holds several patents in the areas of robotics, artificial intelligence, and sustainable energy solutions, showcasing her versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Yasumatsu has worked with top research institutions and universities in Japan, leading innovative projects that have garnered international recognition.

Collaborations: Throughout her career, Yoshie Yasumatsu has collaborated with leading tech companies, government agencies, and fellow inventors to bring her ideas to life and make a lasting impact on the industry.

Conclusion: Yoshie Yasumatsu's dedication to pushing the boundaries of technology and her passion for innovation have solidified her reputation as a pioneering female inventor in Oita and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…